TY - JOUR
T1 - Outcomes of Combined Liver and Pancreas Transplantation
T2 - A Review of the SRTR National Database and a Report of the Largest Single Center Series
AU - Li, Cheukfai
AU - Zhang, Wei
AU - Zhao, Qiang
AU - Ye, Maodong
AU - Ju, Weiqiang
AU - Wu, Linwei
AU - Ma, Yi
AU - Hu, Anbin
AU - Wang, Guodong
AU - Zhu, Xiaofeng
AU - Guo, Zhiyong
AU - Wang, Dongping
AU - He, Xiaoshun
N1 - Funding Information:
We thank all of the patients involved in these studies. We confirmed that all the donors were from donation after citizens' death and none of the donors were prisoners who were executed. Funding. The study was funded by the Project of Doctor scientific research from Guangdong Provincial People's Hospital (2020bq12), National Natural Science Foundation of China (81373156 and 81471583), the Guangzhou Science and Technology Planning Project (201802020027) provided by Guangzhou Science and Technology Innovation Committee, the Special Fund for Science Research by Ministry of Health (201302009), the Key Clinical Specialty Construction Project of National Health and Family Planning Commission of the People's Republic of China, the Guangdong Provincial Key Laboratory Construction Projection on Organ Donation and Transplant Immunology (2013A061401007), Guangdong Provincial international Cooperation Base of Science and Technology (Organ Transplantation) (2015B050501002), Guangdong Provincial Natural Science Funds for Major Basic Science Culture Project (2015A030308010), Guangdong Provincial Natural Science Funds for Distinguished Young Scholars (2015A030306025), Special support program for training high level talents in Guangdong Province (2015TQ01R168), Pearl River Nova Program of Guangzhou (201506010014).
Funding Information:
The study was funded by the Project of Doctor scientific research from Guangdong Provincial People’s Hospital (2020bq12), National Natural Science Foundation of China (81373156 and 81471583), the Guangzhou Science and Technology Planning Project (201802020027) provided by Guangzhou Science and Technology Innovation Committee, the Special
Publisher Copyright:
© Copyright © 2020 Li, Zhang, Zhao, Ye, Ju, Wu, Ma, Hu, Wang, Zhu, Guo, Wang and He.
PY - 2020/10/19
Y1 - 2020/10/19
N2 - Purposes: This study was intended to summarize the characteristics and clinical outcome of Liver and Pancreas (LPTx) recipients in the Scientific Registry of Transplant Recipients (SRTR) database vs. the largest series from the First Affiliated Hospital (FAH), Sun Yat-sen University. Methods: The clinical data of 23 patients who underwent LPTx from 2000 to 2016 in the United States and 31 patients who underwent modified LPTx procedure (known as simplified multivisceral transplantation [SMT]) from 2008 to 2017 in our center were reviewed. The indications, surgical techniques, patient and graft survival, and complications were compared between the two groups. Results: All recipients in the FAH group were diagnosed with type 2 diabetes mellitus, while 10 of 23 recipients were diagnosed with type 1 diabetes mellitus in the SRTR group. The 1-, 3-, and 5-year cumulative patient survival rates were 81, 74, and 74% in the FAH group, respectively, and 51, 47, and 37% in the SRTR group, respectively (P = 0.023). No diabetes was observed during follow-up in the FAH group, while the diabetes recurrence rate was 22.2% in the SRTR group (P = 0.03). Conclusion: With multiple techniques modified and indications changed, the SMT procedure yielded a preferable outcome compared to that of the traditional LPTx procedure in records of SRTR. SMT has become a treatment option for patients with end-stage liver disease and concurrent diabetes.
AB - Purposes: This study was intended to summarize the characteristics and clinical outcome of Liver and Pancreas (LPTx) recipients in the Scientific Registry of Transplant Recipients (SRTR) database vs. the largest series from the First Affiliated Hospital (FAH), Sun Yat-sen University. Methods: The clinical data of 23 patients who underwent LPTx from 2000 to 2016 in the United States and 31 patients who underwent modified LPTx procedure (known as simplified multivisceral transplantation [SMT]) from 2008 to 2017 in our center were reviewed. The indications, surgical techniques, patient and graft survival, and complications were compared between the two groups. Results: All recipients in the FAH group were diagnosed with type 2 diabetes mellitus, while 10 of 23 recipients were diagnosed with type 1 diabetes mellitus in the SRTR group. The 1-, 3-, and 5-year cumulative patient survival rates were 81, 74, and 74% in the FAH group, respectively, and 51, 47, and 37% in the SRTR group, respectively (P = 0.023). No diabetes was observed during follow-up in the FAH group, while the diabetes recurrence rate was 22.2% in the SRTR group (P = 0.03). Conclusion: With multiple techniques modified and indications changed, the SMT procedure yielded a preferable outcome compared to that of the traditional LPTx procedure in records of SRTR. SMT has become a treatment option for patients with end-stage liver disease and concurrent diabetes.
KW - Sun Yat-sen University
KW - end-stage liver disease (ESLD)
KW - scientific registry of transplant recipients (SRTR)
KW - simplified multivisceral transplantation (SMT)
KW - the First Affiliated Hospital (FAH)
KW - type 2 diabetes mellitus (T2DM)
UR - http://www.scopus.com/inward/record.url?scp=85094940546&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85094940546&partnerID=8YFLogxK
U2 - 10.3389/fmed.2020.542905
DO - 10.3389/fmed.2020.542905
M3 - Article
C2 - 33195293
AN - SCOPUS:85094940546
VL - 7
SP - 542905
JO - Frontiers in Medicine
JF - Frontiers in Medicine
M1 - 542905
ER -